Dramatic drop in US pharma exports to Iran

11 February 2013

The US Department of Commerce has recently released data, showing that exports of pharmaceutical products to Iran have decreased by half. This is despite Washington’s claims that “punitive measures” have no humanitarian consequences, noted the Iran-based PressTV news service.

The official US government statistics appear to support the claims of sanctions lawyers and some independent experts that financial sanctions are making it harder for Iranians to obtain medicine despite loopholes designed to permit such trade, added the Al Arabiya News.

According to the data released on February 8, US exports of pharmaceutical products to Iran decreased to $14.8 million from $31.1 million in 2011, while the overall exports to the country increased 9% due to a rise in agricultural exports.

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK

More ones to watch >